C677T and A1298C mutations in the MTHFR gene and survival in colorectal cancer

Journal of Gastrointestinal and Liver Diseases

Volumn 18, Issue 4, 2009, Pages 455-460

  Osian, Gelu ^a   Procopciuc, Lucia ^a   Vlad, Liviu ^a   Iancu, Cornel ^a   Mocan, Teodora ^a   Mocan, Lucian ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Colorectal cancer; MTHFR; Survival

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

AGED; ALLELE; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; WILD TYPE;

AGED; COLORECTAL NEOPLASMS; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 74949097947     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Strand M, Prolla TA, Liskay RM, Petes TD. Destabilisation of tracts of simple repetitive DNA in yeast by mutation affecting DNA mismatch repair. Nature 1993; 365: 274-276.
2. Gudnason V, Stansbie D, Scott J, Bowron A, Nicaud V, Humphries S. C677T (thermolabile alanine/valine) polymorphism in methylenetrahydrofolate reductase (MTHFR): its frequency and impact on homocysteine concentration in different European populations. EARS Group. Atherosclerosis 1998; 136: 347-354.
3. Jacob RA, Gretz DM, Taylor PC, et al. Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women. J Nutr 1998; 128:1204-1212.
4. Kim YI, Pogribny IP, Basnakian AG, et al. Folate deficiency in rats induces DNA strand breaks and hypometylation within the p53 tumor suppressor gene. AM J Clin Nutr 1997; 65: 46-52.
5. Chen J, Giovannucci EL, Hunter DJ. MTHFR polymorphism, methylreplete diets and the risk of colorectal carcinoma and adenoma among U.S. men and women: an example of gene-environment interactions in colorectal tumorigenesis. J Nutr 1999; 129(2S Suppl): 560S-564S.
6. Stern LL, Mason JB, Selhub J, Choi SW. Genomic DNA hypometylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylentetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev 2000; 9: 849-853.
7. Choi SW, Kim YI, Weitzel JN, Mason JB. Folate depletion impairs DNA excision repair in the colon of the rat. Gut 1998; 43: 93-99.
8. Van der Put NM, Gabreels F, Stevens EM, et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube deffects? Am J Hum Genet 1998; 62: 1044-1051.
9. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-113.
10. Ma J, Stampfer MJ, Giovannucci E, et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 1997; 57: 1098-1102.
11. Park KS, Mok JW, Kim JC. The 677C>T mutation in 5,10- methylenetetrahydrofolate reductase and colorectal cancer risk. Genet Test 1999; 3: 233-236.
12. Slattery ML, Potter JD, Samowitz W, Schaffer D, Leppert M. Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 1999; 8: 513-518.
13. Ulrich CM, Kampman E, Bigler J, et al. Colorectal adenomas and the C677T MTHFR polymorphism: evidence for gene-enviroment interaction? Cancer Epidemiol Biomarkers Prev 1999; 8: 659-668.
14. Chen J, Giovannucci E, Hankinson SE, et al. A prospective study of methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms, and risk of colorectal adenoma. Carcinogenesis 1998; 19:,2129-2132.
15. Le v i n e AJ , Si e gmu n d KD, Er v i n CM, e t a l . Th e methylenetetrahydrofolate reductase 677C→T polymorphism and distal colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2000; 9: 657-663.
16. Marugame T, Tsuji E, Inoue H, et al. Methylenetetrahydrofolate reductase polymorphism and risk of colorectal adenomas. Cancer Lett 2000; 151: 181-186.
17. Le Marchand L, Donlon T, Hankin JH, Kolonel LN, Wilkens LR, Seifried A. B-vitamin intake, metabolic genes, and colorectal cancer risk (United States). Cancer Causes Control 2002; 13: 239-248.
18. Chen J, Ma J, Stampfer MJ, Palomeque C, Selhub J, Hunter DJ. Linkage disequilibrium between the 677C>T and 1298A>C polymorphisms in human methylenetetrahydrofolate reductase gene and their contributions to risk of colorectal cancer. Pharmacogenetics 2002; 12: 339-342.
19. Sharp L, Little J, Brockton, et al. Dietary intake of folate and related micronutrients, genetic polymorphisms in MTHFR and colorectal cancer: a population-based case-control study in Scotland. J Nutr 2002; 132(11 Suppl): 3542S.
20. Keku T, Millikan R, Worley K, et al. 5,10-Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites. Cancer Epidemiol Biomarkers Prev 2002; 11: 1611-1621.
21. Choi SW, Mason JB. Folate status: effects on pathways of colorectal carcinogenesis. J Nutr 2002; 132(8 Suppl): 2413S-2418S.
22. Kim YI. Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem 1999; 10: 66-88
23. Verhoeff BJ, Trip MD, Prins MH, Kastelein JJ, Reitsma PH. The effect of a common methylenetetrahydrofolate reductase mutation on levels of homocysteine, folate, vitamin B12 and on the risk of premature atherosclerosis. Atherosclerosis 1998; 141: 161-166.
24. Ulrich CM, Kampman E, Bigler J, et al. Lack of association between the C677T MTHFR polymorphism and colorectal hyperplastic polyps. Cancer Epidemiol Biomarkers Prev 2000; 9: 427-433.
25. Chen J, Giovannucci E, Kelsey K, et al. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res 1996; 56: 4862-4864.
26. Blount BC, Mack MM, Wehr CM, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA 1997; 94: 3290-3295.
27. Duthie SJ, Narayanan S, Blum S, Pirie L, Brand GM. Folate deficiency in vitro induces uracil misincorporation and DNA hypomethylation and inhibits DNA excision repair in immortalized normal human colon epithelial cells. Nutr Cancer 2000; 37: 245-251.
28. Giovannucci E, Chen J, Smith-Warner SA, et al . Methylenetetrahydrofolate reductase, alcohol dehydrogenase, diet, and risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2003; 12: 970-979.
29. Osian G, Procopciuc L, Vlad L. MTHFR polymorphisms as prognostic factors in sporadic colorectal cancer. J Gastrointestin Liver Dis 2007; 16: 251-256.
30. Lahiri DK, Nurnberger JI Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991; 19: 5444.
31. Derwinger K, Wettergren Y, Odin E, Carlsson G, Gustavsson B. A study of the MTHFR gene polymorphism C677T in colorectal cancer. Clin Colorectal Cancer 2009; 8: 43-48.
32. Capitain O, Boisdron-Celle M, Poirier AL, Abadie-Lacourtoisie S, Morel A, Gamelin E. The influence of fluorouracil outcome parameters on tolerance and efficacy in patients with advanced colorectal cancer. Pharmacogenomics J 2008; 8: 256-267.
33. Yoshiya G, Takahata T, Hanada N, et al. Influence of cancer-related gene polymorphisms on clinicopathological features in colorectal cancer. J Gastroenterol Hepatol 2008; 23: 948-953.